Articles > Business magazines > International magazines > Nordic Business Report articles > June 2009

Article: Danish NeuroSearch announces generic name for Huntington's disease drug.(Clinical report)

Article from:
Nordic Business Report
Article date:
June 2, 2009
Copyright

NORDIC BUSINESS REPORT-2 June 2009-Danish NeuroSearch announces generic name for Huntington's disease drug(C)1994-2009 M2 COMMUNICATIONS http://www.m2.com

Danish biopharmaceutical company NeuroSearch A/S (OMX Copenhagen:NEUR) said today (2 June) that the World Health Organisation (WHO) has proposed 'pridopidine' as the INN (International Nonproprietary Name/generic name) for the company's novel drug ACR16.

...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Danish NeuroSearch Q3 net loss shrinks to ...
Nordic Business Report;  November 16, 2009 ;     550 words ...NORDIC BUSINESS REPORT-16 November 2009-Danish NeuroSearch Q3 net loss shrinks to DKK19.3m(C)1994-2009 M2 COMMUNICATIONS http://www.m2.com 16 November 2009 - Danish biopharma ...

Article: Danish NeuroSearch starts trial with ACR325 in ...
Nordic Business Report;  October 8, 2009 ;     700+ words ...NORDIC BUSINESS REPORT-8 October 2009-Danish NeuroSearch starts trial with ACR325 in Parkinson's disease(C)1994-2009 M2 COMMUNICATIONS http://www.m2.com 8 October 2009 ...

Article: Danish NeuroSearch says money enough until 2011.
Nordic Business Report;  August 26, 2009 ;     596 words ...NORDIC BUSINESS REPORT-26 August 2009-Danish NeuroSearch says money enough until 2011(C)1994-2009 M2 COMMUNICATIONS http://www.m2.com 26 August 2009 - Danish biopharma company ...

Article: Danish NeuroSearch, J&J's Janssen form pact on CNS ...
Nordic Business Report;  August 17, 2009 ;     644 words ...NORDIC BUSINESS REPORT-17 August 2009-Danish NeuroSearch, J&J's Janssen form pact on CNS diseases(C)1994-2009 M2 COMMUNICATIONS http://www.m2.com 17 August 2009 ...

Article: Danish NeuroSearch has enough funds until 2011.
ADP News Nordic;  August 26, 2009 ;     654 words ...(ADPnews) - Aug 26, 2009 - Danish biopharma company NeuroSearch A/S (CPH:NEUR) reported today a pretax loss of DKK 178 million (USD 34m/EUR 23.9m) for the first half of 2009, and said it has enough capital resources until at least mid-2011. The cooperation contracts with majors GlaxoSmithKline

Article: Danish NeuroSearch teams up with J&J's Janssen on ...
ADP News Nordic;  August 17, 2009 ;     622 words ...(ADPnews) - Aug 17, 2009 - Danish biopharma company NeuroSearch A/S (CPH:NEUR) has teamed with US-based Janssen Pharmaceutica NV, part of healthcare giant Johnson & Johnson (NYSE:JNJ), or J&J, for the research and development of drugs for central nervous system (CNS) diseases. To

Article: S&P keeps "buy" on Danish NeuroSearch on R&D deal ...
ADP Debt News;  August 17, 2009 ;     525 words ...(ADPnews) - Aug 17, 2009 - S&P Equity Research maintained "buy" on Danish biopharma company NeuroSearch A/S (CPH:NEUR) after it today announced a research and development alliance with Janssen Pharmaceutica NV on central nervous system diseases. Janssen is part of healthcare giant Johnson &

Article: generic name
The Mosby Medical Encyclopedia;      196 words ... ... Mosby Medical Encyclopedia 10-01-1996 generic name, the official name assigned to a drug. A given drug is licensed under its generic name, and all manufacturers of the drug list it by its generic name. However, a drug is usually marketed ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives